Merck & Co Inc

NYSE: MRK
$78.74
-$0.23 (-0.3%)
Closing Price on April 23, 2025

MRK Stock Chart and Intraday Price

MRK Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 2000 GALLOPING HILL ROAD, KENILWORTH, NJ, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 321,543.96M USD
Shares Outstanding 2,532,640,000
Merck & Co Inc is a global healthcare leader known for its innovative pharmaceuticals and animal health products. With a rich history dating back to 1891, Merck has made significant strides in oncology, immunology, neuroscience, and more, offering well-known brands like Keytruda and Januvia. Its pharmaceutical segment focuses on human health, while the Animal Health division provides veterinary pharmaceuticals and services. Merck collaborates with industry giants like AstraZeneca and Bayer, emphasizing its commitment to advancing healthcare across both human and animal sectors.

MRK Articles

Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios. About 20% of the S&P 500 stocks hit a 52-week low before the tariff...
The stock market has been a wild roller coaster ride for the past five years, shifting from bull market to bear and back numerous times. It was a good lesson that stocks don’t just rise in a...
For baby boomers, ultra-safe dividend stocks like these five that can add passive income streams to Social Security benefits.
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
These five S&P 500 stocks look like incredible contrarian ideas for growth and income investors. They pay dependable dividends, have Buy ratings, and are down handily over the past year.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Media personality Jim Cramer often makes bold statements...
With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.
These four mega-cap stocks offer the best total return potential for 2025. Plus, they are all rated Buy at some of the top firms on Wall Street.
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The ‘Dogs of the Dow’ is a well-known strategy first...
These four large-cap dividend stocks offer value, upside potential, and strong dividend coverage. They are top picks for the coming year.
These three dividend-paying Dow stocks dominate the health care sector and look like incredible values now for growth and income investors.
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Many investors can pigeon hole buying dividend stocks as a particular investment style that may not fit with their long-term goals. Indeed, investing in growth stocks has clearly been the winning...